Premia and National Cancer Center Hospital East Announce the Initiation of the LC-SCRUM-AP Genomic..
Establishing a large-scale lung cancer genomic screening platform in the Asia-Pacific region and promoting precision medicine for lung...
top of page
News
- Nov 17, 2022
AmoyDx® Pan Lung Cancer PCR PanelApprovedin Japan as a Companion DiagnosticforLUMAKRAS ®...
TOKYO and XIAMEN, November 14th, 2022 -- Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., (“AmoyDx”) and Precision Medicine Asia Co.,...
- Aug 9, 2022
MHLW Approves AmoyDx® Pan Lung Cancer PCR Panel as Companion Diagnostic for Rozlytrek®...
TOKYO and XIAMEN, August 9, 2022 -- Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., (“AmoyDx”) and Precision Medicine Asia Co., Ltd....
- Apr 20, 2022
Filing Notice for a Manufacturing and Marketing Application for AmoyDx® Pan LungCancer PCR Panel...
TOKYO and XIAMEN, April 20, 2022 -- Riken Genesis Co., Ltd., (“Rigen Genesis”), Amoy Diagnostics Co., Ltd., (“AmoyDx”) and Precision...
- Feb 24, 2022
Notice Concerning Application for Partial Revision of Manufacturing and Marketing Approval...
TOKYO and XIAMEN, February 23, 2022 -- Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., (“AmoyDx”) and Precision Medicine Asia Co.,...
- Jan 14, 2022
AmoyDx and PREMIA Announce the Commercial Launch of the AmoyDx® Pan Lung Cancer PCR Panel in Japan
Xiamen and Hong Kong, January 13, 2022 -- Amoy Diagnostics Co., Ltd., (“AmoyDx”) and PREMIA Holdings (HK) Limited (“PREMIA”) today...
- Aug 17, 2021
AmoyDx® Pan Lung Cancer PCR Panel Receives MHLW Approval as Companion Diagnostic for TEPMETKO®
TOKYO and XIAMEN, August 17, 2021 -- Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., (“AmoyDx”) and Precision Medicine Asia Co.,...
- Jun 30, 2021
AmoyDx® Pan Lung Cancer PCR Panel Receives MHLW Approval as Companion Diagnostic...
TOKYO and XIAMEN, June 30, 2021 (GLOBE NEWSWIRE) -- Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., (“AmoyDx”) and Precision...
- Jun 24, 2019
PREMIA and AmoyDx Announce Strategic Partnership to Establish Asia Cancer Clinical Genomic Network
Hong Kong, China -- June 24, 2019 – Loxo Oncology, Inc., a wholly owned subsidiary of Eli Lilly and Company, has entered into a strategic...
- May 31, 2019
LC-SCRUM Japan Expands Genomic Screening Project to Taiwan and Establishes LC-SCRUM Asia
The National Cancer Center of Japan (“NCC”) today announced the signing of a collaboration between its Cancer Genomic Screening Project...
bottom of page